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Introduction
A link between dermatomyositis and neoplasia has
long been suspected. The precise incidence of this association remains controversial, owing to varying criteria used to diagnose dermatomyositis. Although juvenile dermatomyositis is believed to display no
association with neoplasm, there have been few reported cases of dermatomyositis associated with tumors of any kind in pediatric age group (1-4). We describe another such case and review briefly the current
status of the association of neoplasia with juvenile dermatomyositis.
This female child was normal until the age of 15
months when she began to have fever and swelling of
extremities. When she was 21months old she was
brought to Pediatrics Clinic of University Hospital with
the complaining of fever, flashing on the face, pain
and swelling of the arms and legs and difficulty in
walking. She was born to 17-year-old mother and
parents were first cousins. Physical examination revealed nonpitting edema on dorsal side of the extremities, patchy erythematous and nonitching rash in the
skin, periorbital purplish discoloration associated with
mild edema (heliotrope), proximal muscle weakness
and hypertension (150/80 mmHg). Liver was palpable
2 cm below the costal margin. Laboratory investigations showed Hb, 9.7 gr/dl; Hct, 31%; ESR,
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68mm/h; CPK, 97 IU/L; LDH, 913 IU/LP; AST, 65 IU/
L; ALT, 85 IU/L. IgM were increased, 1720 mg/dl and
261 mg/dl respectively. Rest of the biochemical tests
were normal. EMG revealed small, short duration polyphasic motor unit potentials. Muscle biopsy showed
perifascicular muscle fiber atrophy and scattered muscle fiber necrosis and regeneration, and mononuclear
cell infiltration of muscle fibers. Immunocytochemical
studies demonstrated endomysial IgG deposition. Skin
biopsy from sclerotic area showed increased collagen
fibers and atrophic sweat glands. Renal biopsy was
normal. On the basis of the presence of proximal muscle weakness, chronic inflammatory changes in skin
and muscle biopsy and characteristic EMG findings the
diagnosis of dermatomyositis was made.
Hypertension was treated with antihypertensive
drugs. Prednisolone therapy (2 mg/kg) was instituted
to treat active dermatomyositis. ESR was gradually decreased from 68 mm/h to 20 mm/h. Prednisolone was
reduced to 5 mg/d within one month. After the following-up as out-patient for five months, she was hospitalized again because of the gradually developing
subcutaneous solid nodules and plaques. She had difficulties in walking and sitting. Physical examination
revealed marked proximal muscle weakness and hepatosplenomegaly. Laboratory studies showed ESR, 50
mm/h; LDH, 250 IU/L; CPK, 250 IU/L. Rest of the laboratory results were unremarkable. Plain radiographs
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of the extremities showed widespread subcutaneous
calcification (Figure 1). With these clinical and laboratory findings, she was diagnosed to have universal
calcinosis as a complication of juvenile dermatomyositis. Since high level of CPK and increased
ESR were accepted as an activation criteria, full dose
of prednisolone (2 mg/kg) was given again for two
more months and continued with the dose of 10 mg/
d. At the end of the six-month-follow-up period, she
showed remarkable improvement clinically and steroid
treatment was stopped. Calcified nodules and plaques
were nearly disappeared at that time. Within the following six months, at the age of three years and eight
months, all subcutaneous calcified deposits disappeared
radiographically.
The child was symptom-free until the age of five
when she began to show paleness and weakness in
addition to masses in neck and abdominal enlargement. Physical examination revealed axillar, cervical
and inguinal multiple Iymphadenopathy, and hepatosplenomegaly. No skin lesion other than localized
scar tissues all over the body was observed. La-

boratory investigations showed Hb, 6.8 gr/dl; Hct,
20% WBC, 32000/mm3 with over 90% blasts; ESR,
72 mm/h; platelets, 72000/mm3; ALT, 24 IU/l; AST,
14 IU/L; CPK, 60 IU/L; LDH,746-2406 IU/L (in multiple measurements). Bone marrow examination revealed
%95 Iymphoblasts (33%L2, 67% L1type blasts; according to FAB classification) with PAS (-), Sudan
black (-), peroxidase (-). Flowcytometric examination
showed CD19(+), CD20(+), CD22(-), CD10(+) and
HLA DR(+). Rest of the laboratory tests were normal
and final diagrosis was pre B cell acute Iymphoblastic
leukemia and ALL BFM 90 therapy protocol was begun.
Juvenile dermatomyositis closely resembles its adult
counterpart. Important differences distinguish juvenile
dermatomyositis from the adult-onset disease, however, apart from the age of the patient (1). Calcinosis
is much more likely to occur in children than adults as
a complication and chronic sequel even after the active
disease process is arrested. Angiitis of muscle is generally more intense in children, and vasculitis of other
organs is more common than in adults (5). Finally, it
is rarely associated with malignancy in childhood except for a few reports (1-4).
Although most of them are retrospective, recent
studies have shown an increased incidence of malignancy among adult patients with dermatomyositis
when compared with controls without myositis (6,7).
The types of neoplasms found in association with dermatomyositis seem to parallel those observed in general population (7,8). Malignancies with hematopoietic
origin have also been described, such as Iymphoma
(7,9), and leukemia (10). The relationship in time between the onset of dermatomyositis and the discovery
of malignancy is quiet variable. The preceding neoplasm is not unusual (30%), although it is somewhat
more common for the dermatomyositis to be diagnosed before the tumor (70%); in either sequence,
the two processes generally are discovered within 2-3
years of each other, though longer gaps have been
noted (11). This time interval in our case was about
three years after the initial diagnosis of dermatomyositis. It may be suggested that diagnosis of
dermatomyositis and malignancy separated widely in
time are probably coincidental findings. Although only
16-20% of the patients with dermatomyositis have
onset childhood (5), namely juvenile dermatomyositis
has been found in the literature, except a few case reports (1-4).

Figure 1.
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In sum, we believe our case is a rare example of

F. F. ÖZKİNAY, et al.

dermatomyositis associated with leukemia. Although
the concurrens of these two events could still be a
chance association, Such reports will rise, from time
to time the question whether there is linked between

juvenile dermatomyositis and malignancy. This will
prompt us to perform larger and collaborative studies
to determine the exact relationship of these two
events.
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